Evidence map›Paper›PMID 8609227›Full record

Trial reportThe Journal of clinical investigation1996

Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.

T van der Poll, S M Coyle, K Barbosa, C C Braxton, S F Lowry

Open access · bronzeAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical investigation, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 1 synthesis or guideline pooled it, 517 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Trial
  4. Trial
  5. Nicotine exposure alters in vivo human responses to endotoxin.Clinical and experimental immunology · 2007
    Trial
  6. Circulating adiponectin levels during human endotoxaemia.Clinical and experimental immunology · 2003
    Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Validity of mental and physical stress models.Neuroscience and biobehavioral reviews · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

T van der PollCornell University Medical College, Department of Surgery, New York, NY 10021, USA.
S M Coyle
K Barbosa
C C Braxton
S F Lowry
Cornell University · USAcademic Medical Center · NL

Funding

SKELETAL MUSCLE PROTEIN RESPONSE TO INJURY AND REPLETIONR01GM034695 · NIGMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CORBETT, SIOBHAN A · 1985 to 2011
$2.8M
TRAUMA AND INJURY BIOLOGY RESEARCH TRAINING PROGRAMT32GM008466 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI KENT, K CRAIG · 1992 to 2007
$792k
NCRR NIH HHS RR0047NIGMS NIH HHS R01 GM 34695NIGMS NIH HHS T32 GM 08466
6 · The paper itself

Abstract

Short-term preexposure of mononuclear cells to epinephrine inhibits LPS-induced production of TNF, whereas preexposure for 24 h results in increased TNF production. To assess the effects of epinephrine infusions of varying duration on in vivo responses to LPS, the following experiments were performed: (a) Blood obtained from eight subjects at 4-24 h after the start of a 24-h infusion of epinephrine (30 ng/kg per min) produced less TNF after ex vivo stimulation with LPS compared with blood drawn before the start of the infusion, and (b) 17 healthy men who were receiving a continuous infusion of epinephrine (30 ng/kg per min) started either 3 h (EPI-3; n = 5) or 24 h (EPI-24; n = 6) were studied after intravenous injection of LPS (2 ng/kg, lot EC-5). EPI-3 inhibited LPS-induced in vivo TNF appearance and also increased IL-10 release (both P < 0.005 versus LPS), whereas EPI-24 only attenuated TNF secretion (P = 0.05). In separate in vitro experiments in whole blood, epinephrine increased LPS-induced IL-10 release by a combined effect on alpha and beta adrenergic receptors. Further, in LPS-stimulated blood, the increase on IL-10 levels caused by epinephrine only marginally contributed to concurrent inhibition of TNF production. Epinephrine, either endogenously produced or administered as a component of sepsis treatment, may have a net antiinflammatory effect on the cytokine network early in the course of systemic infection.

Indexed as

EndotoxinsAdultEpinephrineHumansInfusions, IntravenousInterleukin-10MaleReceptors, Adrenergic, alphaReceptors, Adrenergic, betaToxemiaTumor Necrosis Factor-alphaEndotoxinsEpinephrineInterleukin-10Receptors, Adrenergic, alphaReceptors, Adrenergic, betaTumor Necrosis Factor-alpha

Identifiers

PMID8609227
PMCPMC507108
OpenAlexW2164816346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.